(NASDAQ:ITRM), DUBLIN, Ireland and CHICAGO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today provided a business update. Recent Events Specialty Distributor Now […]
(Other OTC:HLYK),(OTC US:HLYK), NAPLES, Fla., Nov. 24, 2025 (GLOBE NEWSWIRE) — via IBN — HealthLynked Corp. (OTCQB:HLYK), a patient-centric healthcare technology company, announced today that it has entered into a Capital Market Advisory Agreement with NE Holdings, LLC, a Florida-based consulting firm specializing in senior exchange readiness and capital markets strategy. This engagement supports HealthLynked's
(NASDAQ:SLNO), REDWOOD CITY, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 37th Healthcare Conference on Thursday, December 4, 2025,
(PinkSheets:PREM),(Pinksheets:PREM), CARLSBAD, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — Premier Air Charter Holdings Inc. (OTCID: PREM) (“Premier Air Charter,” “Premier,” “PAC,” or the “Company”) welcomed professional golfer and SiriusXM radio host Rocco Mediate for an exclusive tour of its facilities, where he met and spoke with team members across multiple departments. Widely celebrated for his
(NasdaqGM:GCT), EL MONTE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced that Larry Wu, it's Founder and Chief Executive Officer, and Erica Wei, its Chief Financial Officer, will conduct one-on-one meetings with investors
New findings from Phase 2 adjunctive study evaluating the characteristics of OFF time improvement with solengepras, a novel, non-dopaminergic GPR6 inhibitor; poster selected as one of 10 featured selections for the Poster Tour Results from Phase 2 ASCEND trial of solengepras as a monotherapy treatment for patients with early-stage Parkinson's disease to be presented BOSTON,
HONG KONG, Nov. 24, 2025 (GLOBE NEWSWIRE) — Kodak proudly announces two flagship Wi-Fi smart digital frames — the 10.1-inch RWF-109V and the 14.1-inch RWF-141. More than just screens, they act as bridges between the cloud and real life, bringing photos from your phone and cloud storage back into your living space, displaying memories in
(NasdaqGM:LBRX), NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that Heather Turner, Chief Executive Officer, will present at the Piper Sandler 37th Annual Healthcare Conference in New York, NY on Wednesday, December 3, 2025, at 9:30 a.m. ET. A live webcast of the
(Euronext Amsterdam:ASML),(NASDAQ:ASML), ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average price Total repurchased value 17-Nov-25 41,310 EUR875.57 EUR36,169,801 18-Nov-25 41,665 EUR868.11 EUR36,169,728 19-Nov-25 41,408 EUR873.50 EUR36,169,776 20-Nov-25 39,960 EUR905.16
(Paris:STMPA),(NYSE:STM), STMicroelectronics announces status of common share repurchase program Disclosure of Transactions in Own Shares – Period from November 17, 2025 to November 21, 2025 AMSTERDAM – November 24, 2025 — STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global semiconductor leader serving customers across the spectrum of electronics applications, announces full details of its common